Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Feb 2026 for Eikon Therapeutics, Inc..
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Lux Venture Partners V, LLC: trading record in brief
Lux Venture Partners V, LLC appears in our data through filings on Eikon Therapeutics, Inc. shares, published by SEC (Form 4). In total, 5 filings cover trades dated from 4 February 2026 to 6 February 2026.
Every open-market trade on record is a purchase: 2 purchases worth €4.2M, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The latest filing, published on 6 February 2026, reports a transaction in Eikon Therapeutics, Inc. The clock since the last published purchase (6 February 2026) now reads 260 days. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Lux Venture Partners V, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
2,387,705 sharesCommon StockSEC:0001193125-26-041544:2
1,151,540 sharesCommon StockSEC:0001193125-26-041544:3
2,155,765 sharesCommon StockSEC:0001193125-26-041544:4
138,888 shares@ US$18.00100.0% of flowCommon StockSEC:0001193125-26-041544:0
Canonical exit: 5 May 2026 (T+90)
4 of 3 declarations
